Economic evaluations for intensive care unit randomised clinical trials in Australia and New Zealand: Practical recommendations for researchers
- 25 March 2022
- journal article
- research article
- Published by Elsevier in Australian Critical Care
- Vol. 36 (3) , 431-437
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical OutcomesMedical Decision Making, 2013
- Mapping for economic evaluationBritish Medical Bulletin, 2011
- Sample Size Determination for Cost-Effectiveness TrialsPharmacoEconomics, 2011
- Time Trade-Off Derived EQ-5D Weights for AustraliaValue in Health, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe SepsisJAMA, 2010
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- Optimal sample size determinations from an industry perspective based on the expected value of informationClinical Trials, 2008
- The value of information and optimal clinical trial designStatistics in Medicine, 2005
- An economic approach to clinical trial design and research priority-settingHealth Economics, 1996